Published in Naunyn Schmiedebergs Arch Pharmacol on October 01, 1998
Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol (1971) 6.97
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29
Screens for anti-inflammatory drugs. J Pharm Pharmacol (1971) 3.24
Biological properties of carrageenan. J Pharm Pharmacol (1972) 2.58
Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol (1992) 2.32
A histopathological and pharmacological analysis of the mode of action of nonsteroidal anti-inflammatory drugs. J Pathol (1971) 2.15
Anti-phospholipase proteins. Prostaglandins (1984) 1.93
Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther (2000) 1.81
Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol (1982) 1.74
Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol (1993) 1.72
A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology (1994) 1.54
Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol (1992) 1.45
Hydrocortisone-induced inhibitor of prostaglandin biosynthesis in rat leucocytes. Br J Pharmacol (1980) 1.36
The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leucocytes is correlated with intracellular macrocortin levels. Br J Pharmacol (1981) 1.34
Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes. Br J Pharmacol (1979) 1.34
Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia (2002) 1.33
Structural elucidation of a new cytotoxin isolated from mussels of the Adriatic sea. J Org Chem (2001) 1.30
Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol (1995) 1.16
Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett (1997) 1.15
Inflammatory effects of Salmonella typhimurium porins. Infect Immun (1990) 1.14
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur J Pharmacol (1992) 1.11
Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J Clin Lab Anal (2005) 1.09
The mechanism of the inflammatory effect of carrageenin. Eur J Pharmacol (1968) 1.07
The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat. Mol Med (2001) 1.03
Some pharmacodynamic properties of carrageenin in the rat. Br J Pharmacol (1970) 1.03
Indomethacin and prostaglandins. Eur J Pharmacol (1972) 1.01
Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest (1999) 1.01
Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol (1987) 1.01
Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fatty Acids (1996) 1.00
Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am J Physiol (1994) 1.00
Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett (2007) 1.00
Multiple control of inflammation by glucocorticoids. Agents Actions (1986) 0.99
Leucocyte migration and lysosomal enzymes release in rat carrageenin pleurisy. Agents Actions (1975) 0.98
Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut (2006) 0.97
The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br J Pharmacol (2010) 0.96
Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol (1999) 0.96
Hyaluronic acid modulates acute and chronic inflammation. Agents Actions (1994) 0.96
Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages. FEBS Lett (1998) 0.95
Non-steroidal anti-inflammatory drugs and leucocyte emigration. J Pharm Pharmacol (1972) 0.95
A mass fragmentographic procedure for the simultaneous determination of HETE and PGF2alpha in the central nervous system. Prostaglandins (1978) 0.94
Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic. Eur Rev Med Pharmacol Sci (2013) 0.94
Enhancement of carrageenin foot oedema by 1,10 -phenanthroline and evidence for the bradykinin as endogenous mediator. Agents Actions (1975) 0.93
Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol (2007) 0.93
Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. FEBS Lett (2001) 0.92
Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB. Br J Pharmacol (1998) 0.92
17beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. Endocrinology (2000) 0.92
The anti-inflammatory effect of glucocorticoid-induced phospholipase inhibitory proteins. Agents Actions (1985) 0.92
In vitro interactions of PGE and cAMP with murine and human erythroid precursors. Blood (1980) 0.91
Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci (2012) 0.91
Preferential utilization of endogenous arachidonate by cyclo-oxygenase in incubations of human platelets. FEBS Lett (1983) 0.91
Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci (1996) 0.91
Bone disease in the setting of HIV infection: update and review of the literature. Eur Rev Med Pharmacol Sci (2013) 0.91
Socioeconomic determinants of influenza vaccination among older adults in Italy. Prev Med (2010) 0.89
Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. Br J Pharmacol (2011) 0.89
Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats. Eur J Pharmacol (2001) 0.88
Relationship between nitric oxide and prostaglandins in carrageenin pleurisy. Biochem Pharmacol (1998) 0.88
LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. Eur Rev Med Pharmacol Sci (2013) 0.88
Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages. Int Immunopharmacol (2005) 0.88
Modulation of granuloma formation by endogenous nitric oxide. Eur J Pharmacol (1994) 0.87
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.87
Kidney disease in HIV-infected patients. Eur Rev Med Pharmacol Sci (2013) 0.87
Endogenous nitric oxide modulates morphine-induced constipation. Biochem Biophys Res Commun (1991) 0.87
Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. Inflamm Res (2000) 0.87
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in rats. Neuropharmacology (1994) 0.86
Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur J Pharmacol (1994) 0.86
Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. Eur J Pharmacol (1995) 0.86
Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins). Agents Actions (1990) 0.86
The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity in J774 macrophages. Phytomedicine (2002) 0.85
PGF2 alpha, thromboxane B2 and HETE levels in gerbil brain cortex after ligation of common carotid arteries and decapitation. Prostaglandins (1979) 0.85
[Pharmacological research on a deethylate metabolite of 4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide (metoclopramide)]. Boll Chim Farm (1976) 0.85
Glycolipids from sponges. VII. Simplexides, novel immunosuppressive glycolipids from the Caribbean sponge Plakortis simplex. Bioorg Med Chem Lett (1999) 0.85
Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol (1994) 0.85
The mode of action of tiaramide hydrochloride: a new antiasthmatic drug. Pharmacol Res Commun (1979) 0.85
HSF1/hsp72 pathway as an endogenous anti-inflammatory system. FEBS Lett (2001) 0.84
Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock (1997) 0.84
Prostaglandins, leucocytes and non-steroidal anti-inflammatory drugs. Pol J Pharmacol Pharm (1974) 0.84
Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F2alpha by lipopolysaccharide-activated J774 macrophages. Inflamm Res (1999) 0.84
beta-Adrenoceptor activation induces prostaglandin E2 generation in guinea-pig trachea. Eur J Pharmacol (1981) 0.84
Hepatocellular carcinoma in HIV positive patients. Eur Rev Med Pharmacol Sci (2012) 0.84